Podcast Episodes
Back to SearchBig Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
Episode 251
We love to hear from our listeners. Send us a message.
On today's episode I'm speaking with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience building…
Published on 4 months, 2 weeks ago
The Implications Of China's Growing Biotech Industry With Allan Shaw
Episode 250
We love to hear from our listeners. Send us a message.
Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global inno…
Published on 4 months, 3 weeks ago
How To Be A CFO With Insmed's Sara Bonstein
Episode 249
We love to hear from our listeners. Send us a message.
On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provid…
Published on 5 months ago
Deal And Investment Trends With Investment Banker David Sans
Episode 248
We love to hear from our listeners. Send us a message.
Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engi…
Published on 5 months, 1 week ago
Business of Biotech 2.0 with Ben Comer
We love to hear from our listeners. Send us a message.
After nearly five years as host of the Business of Biotech podcast, Matt Pillar is handing the mic over to the voice of the Business of Biotech …
Published on 5 months, 2 weeks ago
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
Episode 246
We love to hear from our listeners. Send us a message.
In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latigo Biother…
Published on 5 months, 3 weeks ago
BoB@JPM: Kasper Roet, Ph.D., QurAlis
Episode 245
We love to hear from our listeners. Send us a message.
Dr. Kasper Roet's hands-on work at the Dutch Brain Bank informed his leadership at the biotech QurAlis, where three clinical programs targeting …
Published on 5 months, 4 weeks ago
BoB@JPM: Rick Modi, Affinia Therapeutics
Episode 244
We love to hear from our listeners. Send us a message.
The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation with Affi…
Published on 6 months ago
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
Episode 243
We love to hear from our listeners. Send us a message.
On this episode of the Business of Biotech, recorded on-site at the 2025 JP Morgan Healthcare Conference, we explore a new approach to biotech f…
Published on 6 months, 1 week ago
BoB@JPM: Tom Chalberg, Ph.D., Genascence
We love to hear from our listeners. Send us a message.
Recorded in-person at the JP Morgan Healthcare Conference in San Franscisco, this episode finds Matt Pillar and Ben Comer exploring the evolutio…
Published on 6 months, 3 weeks ago